Funders › CA › Curebound › 2024
Grants paid by Curebound, tax year 2024
EIN 46-0552414 · San Diego, CA · Form 990, Schedule I · NTEE G123
In tax year 2024, Curebound (EIN 46-0552414) reported 10 grants paid totaling $7,083,484. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2024
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | The Regents of University of California Uc San Diego La Jolla, CA | A | $4,721,574 | paid | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | 202532749349301113 |
| 2024 | La Jolla Institute for Immunology La Jolla, CA | A | $532,374 | paid | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | 202532749349301113 |
| 2024 | Sanford Burnham Prebys La Jolla, CA | A | $411,561 | paid | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | 202532749349301113 |
| 2024 | Beken Bio Inc San Diego, CA | A | $250,000 | paid | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | 202532749349301113 |
| 2024 | Resolute Science Inc San Diego, CA | A | $250,000 | paid | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | 202532749349301113 |
| 2024 | Palm Therapeutics Inc San Diego, CA | A | $250,000 | paid | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | 202532749349301113 |
| 2024 | Seren Bio Corp Encinitas, CA | A | $250,000 | paid | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | 202532749349301113 |
| 2024 | The Salk Institute for Biological Studies La Jolla, CA | A | $207,926 | paid | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | 202532749349301113 |
| 2024 | Scripps Research La Jolla, CA | A | $188,618 | paid | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | 202532749349301113 |
| 2024 | Rady Children's Hospital San Diego, CA | A | $21,431 | paid | SEE DETAIL IN PART IVCANCER RESEARCH ACROSS FIVE RESEARCH PILLARS; INCLUDING PREVENTION AND DIAGNOSTIC TOOLS, NOVEL APPROACHES AND NEW THERAPEUTIC PLATFORMS, IMMUNOTHERAPIES AND PERSONALIZED VACCINES, CANCER EQUITIES, AND PEDIATRIC CANCERS. | 202532749349301113 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.